Medpace
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Medpace and other ETFs, options, and stocks.About MEDP
Medpace Holdings, Inc. engages in the provision of outsourced clinical development services to the biotechnology, pharmaceutical, and medical device industries. The firm's services include medical department, clinical trial management, data-driven feasibility, study-start-up, clinical monitoring, regulatory affairs, patient recruitment and retention, medical writing, biometrics and data sciences, pharmacovigilance, core laboratory, laboratories, clinics, and quality assurance.
CEOAugust James Troendle
CEOAugust James Troendle
Employees5,900
Employees5,900
HeadquartersCincinnati, Ohio
HeadquartersCincinnati, Ohio
Founded1992
Founded1992
Employees5,900
Employees5,900
MEDP Key Statistics
Market cap8.77B
Market cap8.77B
Price-Earnings ratio22.35
Price-Earnings ratio22.35
Dividend yield—
Dividend yield—
Average volume925.99K
Average volume925.99K
High today$297.34
High today$297.34
Low today$282.84
Low today$282.84
Open price$293.42
Open price$293.42
Volume1.41M
Volume1.41M
52 Week high$459.77
52 Week high$459.77
52 Week low$250.05
52 Week low$250.05
MEDP News
Simply Wall St 18h
Medpace Holdings, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their PredictionsA week ago, Medpace Holdings, Inc. ( ) came out with a strong set of quarterly numbers that could potentially lead to a re-rate of the stock. It was overall a p...
Seeking Alpha 2d
Medpace drops despite Q1 beat amid disappointing performance metricsMedpace (NASDAQ:MEDP) shares fell on Tuesday after the contract research organization disappointed Wall Street with its key performance metrics for Q1 2025, eve...
Benzinga 2d
Medpace Holdings Reports Q1 Earnings, Shares Move LowerMedpace Holdings Inc MEDP reported first-quarter financial results after market close on Monday. Here’s a look at the key metrics from the quarter. Q1 Revenue:...
Analyst ratings
85%
of 13 ratingsBuy
15.4%
Hold
84.6%
Sell
0%